Nasopharyngeal Dendritic Cell Sarcoma, Not Otherwise Specified, in a 34-Year-Old Man

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dendritic cell sarcoma, not otherwise specified (NOS), is an entity that is poorly defined because of its rarity and poorly understood pathogenesis. It is characterized by positive immunohistochemical staining for S-100 and CD1a, along with an absence of cytoplasmic Birbeck granules on electron microscopy. We report the case of a surgically inaccessible nasopharyngeal dendritic cell sarcoma, NOS, in a 34-year-old man. Treatment with chemotherapy along with adjuvant radiation therapy was successful in decreasing the size of the nasopharyngeal mass, and the patient remained free of any evidence of recurrence nearly 5 years after treatment.

Cite

CITATION STYLE

APA

Horton, W. B., Joyner, D. A., Daley, W. P., Pitman, K. T., & Khan, M. A. (2011). Nasopharyngeal Dendritic Cell Sarcoma, Not Otherwise Specified, in a 34-Year-Old Man. Ear, Nose and Throat Journal, 90(6), E7–E10. https://doi.org/10.1177/014556131109000617

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free